Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XA Platinum compounds
L01XA03 Oxaliplatin
D01790 Oxaliplatin (JP18/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Antineoplastics
Alkylating Agents
Alkylating Agents, Other
Oxaliplatin
D01790 Oxaliplatin (JP18/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
4 Agents affecting cellular function
42 Antineoplastics
429 Miscellaneous
4291 Other Antitumors
D01790 Oxaliplatin (JP18/USP/INN)
Drug groups [BR:br08330]
Antineoplastic
DG01679 Platinum compound
D01790 Oxaliplatin
Transporter substrate
DG02858 SLC22A1 substrate
D01790 Oxaliplatin
DG02854 SLC22A2 substrate
D01790 Oxaliplatin
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D01790 Oxaliplatin
D01790 Oxaliplatin injection
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D01790
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D01790
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D01790
Drug metabolizing enzymes and transporters [br08309.html]
Drug transporters
D01790